PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Washington, Seattle, Washington, USA.\', \'Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'Seattle Cancer Care Alliance, Seattle, Washington, USA.\', \'Department of Laboratory Medicine and Pathology, and.\', \'Department of Global Health, University of Washington, Seattle, Washington, USA.\', \'Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.\', \'Kearney, Chicago, Illinois, USA.\', \'Department of Epidemiology, University of Washington, Seattle, Washington, USA.\', \'Benaroya Research Institute, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/JCI144930144930
?:hasPublicationType
?:journal
  • The Journal of clinical investigation
is ?:pmid of
?:pmid
?:pmid
  • 33320842
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33320842>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33320842>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all